Idorsia (IDRSF) News Today $3.30 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock IDRSF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Idorsia shares new analyses of daridorexant for patients with insomnia at World Sleep 2025September 10, 2025 | globenewswire.comIdorsia Ltd (IDRSF) TRYVIO Investor Q&A Webcast And Conference Call (Transcript)September 8, 2025 | seekingalpha.comIdorsia highlights very low real-world abuse potential of DORA class for insomnia treatment at WSC 2025September 8, 2025 | globenewswire.comIdorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN - a US initiative to transform care for patients with difficult-to-control hypertensionSeptember 5, 2025 | prnewswire.comIdorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN – a US initiative to transform care for patients with difficult-to-control hypertensionSeptember 5, 2025 | globenewswire.comInvitation to Idorsia's aprocitentan (TRYVIO/JERAYGO) investor Q&A webcast and conference callSeptember 3, 2025 | globenewswire.comIdorsia furthers the science of sleep and insomnia at World Sleep 2025September 1, 2025 | globenewswire.comIdorsia's TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertensionAugust 28, 2025 | globenewswire.comIdorsia price target raised to CHF 2 from CHF 1 at Deutsche BankAugust 22, 2025 | msn.comIdorsia publishes end results of repurchase offer for its 2025 and 2028 convertible bondsAugust 19, 2025 | globenewswire.comIdorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bondsAugust 11, 2025 | globenewswire.comStrong sales acceleration of QUVIVIQ drives Idorsia toward profitability – H1 2025 resultsJuly 30, 2025 | globenewswire.comInvitation to Idorsia's HY 2025 Financial Reporting webcast and conference call with our new CEO Srishti GuptaJuly 23, 2025 | globenewswire.comA factory in a lab: Idorsia's breakthrough synthetic glycan vaccine platform validated for the first time in humansJune 30, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Bondholders approve amended terms of the 2025 and 2028 convertible bondsJune 25, 2025 | finanznachrichten.deIdorsia launches repurchase offer for its 2025 and 2028 convertible bondsJune 25, 2025 | globenewswire.comIdorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreementJune 24, 2025 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of IdorsiaJune 10, 2025 | finanznachrichten.deIdorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of IdorsiaJune 10, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Idorsia publishes invitations to bondholder meetingsJune 6, 2025 | finanznachrichten.deIdorsia publishes invitations to bondholder meetingsJune 6, 2025 | globenewswire.comIdorsia Pharmaceuticals Ltd: Shareholders vote in favor of all proposals by the Board at Idorsia's Annual General Meeting 2025May 28, 2025 | finanznachrichten.deShareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2025May 28, 2025 | uk.finance.yahoo.comShareholders vote in favor of all proposals by the Board at Idorsia's Annual General Meeting 2025May 28, 2025 | globenewswire.comNew funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia’s path to profitabilityMay 21, 2025 | finance.yahoo.comNew funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia's path to profitabilityMay 21, 2025 | globenewswire.comIdorsia issues invitation to the 2025 Annual General Meeting of ShareholdersMay 2, 2025 | globenewswire.comHigher cantonal composition authority approved the amendments to the terms of the 2025 convertible bondApril 16, 2025 | finance.yahoo.comIdorsia Pharmaceuticals Ltd: Higher cantonal composition authority approved the amendments to the terms of the 2025 convertible bondApril 16, 2025 | finanznachrichten.deIdorsia Pharmaceuticals Ltd: US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirementApril 9, 2025 | finanznachrichten.deUS FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirementApril 9, 2025 | finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia publishes its Annual Report 2024March 27, 2025 | finanznachrichten.deIdorsia publishes its Annual Report 2024March 27, 2025 | globenewswire.comIdorsia Ltd (IDIA) Receives a Hold from Kepler CapitalMarch 19, 2025 | markets.businessinsider.comUS FDA removes REMS requirement for TRYVIO (aprocitentan) – minimizing the burden on the healthcare delivery systems and patientsMarch 17, 2025 | uk.finance.yahoo.comIdorsia Pharmaceuticals Ltd: Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturiaMarch 15, 2025 | finanznachrichten.deIdorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturiaMarch 14, 2025 | globenewswire.comIdorsia Ltd (IDRSF) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comIdorsia Ltd (IDRSF) (Q4 2024) Earnings Call Highlights: Strategic Moves and Financial ResilienceMarch 5, 2025 | gurufocus.comFull Year 2024 Idorsia Ltd Earnings Call TranscriptMarch 4, 2025 | gurufocus.comIdorsia announces financial results for 2024March 4, 2025 | globenewswire.comKepler Capital Remains a Hold on Idorsia Ltd (IDIA)February 27, 2025 | markets.businessinsider.comInvitation to Idorsia's Full Year 2024 Financial Reporting webcast and conference callFebruary 27, 2025 | globenewswire.comBondholders approve amended terms of the 2025 convertible bondsFebruary 26, 2025 | uk.finance.yahoo.comIdorsia’s Tryvio deal collapses, forcing company to find cash urgentlyFebruary 26, 2025 | finance.yahoo.comIdorsia is released from exclusivity constraint regarding the global rights to aprocitentan – now pivoting to alternative partiesFebruary 26, 2025 | globenewswire.comIdorsia and Viatris update their collaboration for selatogrel and cenerimodFebruary 26, 2025 | globenewswire.comIdorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operationsFebruary 26, 2025 | globenewswire.comKepler Capital Sticks to Their Hold Rating for Idorsia Ltd (IDIA)February 13, 2025 | markets.businessinsider.comIdorsia Pharmaceuticals Ltd: Idorsia publishes the resolutions for the upcoming bondholder meetingFebruary 12, 2025 | finanznachrichten.de Get Idorsia News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRSF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IDRSF Media Mentions By Week IDRSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRSF News Sentiment▼0.560.92▲Average Medical News Sentiment IDRSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRSF Articles This Week▼31▲IDRSF Articles Average Week Get the Latest News and Ratings for IDRSF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Idorsia and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SXTPW News Today AGNPF News Today AKBLF News Today DRTSW News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IDRSF) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idorsia Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Idorsia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDRSF Stock Alerts